By John Ballard
Anybody who ever got stoned knew this, but science is finally catching up.
...Sakuda learned of a study being conducted by Charles Grob, a psychiatrist and researcher at Harbor-U.C.L.A. Medical Center who was administering psilocybin � an active component of magic mushrooms � to end-stage cancer patients to see if it could reduce their fear of death. Twenty-two months before she died, Sakuda became one of Grob�s 12 subjects. When the research was completed in 2008 � (and published in the Archives of General Psychiatry last year) � the results showed that administering psilocybin to terminally ill subjects could be done safely while reducing the subjects� anxiety and depression about their impending deaths.
The article is nearly four thousand words long. Go read it and make up your own commentary.
The banning of even experimental use of LSD has cost society a lot. It's not only beneficial for folks with terminal illnesses, it can be used in treating alcoholism. I suspect it might also be useful for other psychological problems. With with the current federal policy, we may never know. Hopefully, some Europeans may be a little more rational. It seems like scientists are able to research with psilocybin, so there is some hope for sanity.
ReplyDelete